3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
4
Venous Thrombosis
2
Venous Thromboembolism
2
Pulmonary Embolism
2
Thrombosis
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Hot Flashes
1
Cushing Syndrome
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Non-small Cell Lung Cancer
1
Interventions
apixaban
3
Warfarin
2
Dalteparin
2
Aspirin
2
salicylhydroxamic acid
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
edoxaban
1
Simvastatin
1
Rivaroxaban
1
Radiotherapy, Conformal
1
Paclitaxel
1
Observation
1
Injections
1
Fondaparinux
1
Enoxaparin
1
Docetaxel
1
Data Collection
1
Dabigatran
1
Clopidogrel
1
Arginine Vasopressin
1
Arginine
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thrombosis
×
Dabigatran
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts